WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com. An audio replay of the call will be available begin ...

Johnson & Johnson (NYSE:JNJ) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. J&J Announces Second Major Spinoff, Plans to Separate Orthopedics Division Johnson & Johnson (NYSE:JNJ) is an American multinational pharmaceutical, biotech, and medical technologies company. On Oc‍tober 14,​ the company⁠ announced that it will spin​ off i‌ts orthopedics division into a​ sepa‌rate company within the next 18 to 24 months. This move marks its second major spin-off in two ye‍a⁠rs as the h ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer put under the microscope. Cramer recalled his discussion with the company’s CEO, and commented: “What else might work? Last Friday on the show, we had Joaquin Duato. He’s the CEO of Johnson & Johnson, and he told a remarkable story about game-changing cancer drugs and medical devices, especially their excellent cardio products. Now, I’ve been worried about the talc lawsuits that they have, but I believe the risk from the asbestos and the baby po ...

Core Viewpoint - Stryker is set to report its financial results for the third quarter of fiscal year 2025 on October 30, 2025, with a press release and a subsequent webcast to discuss the results [1][2]. Financial Reporting - The financial results will be announced in a press release at approximately 4:05 p.m. ET on October 30, 2025, covering the third quarter that ended on September 30, 2025 [1]. - A webcast will be held at 4:30 p.m. ET on the same day to discuss the results, with an archive available two hours after the live call [2]. Company Overview - Stryker is a global leader in medical technologies, focusing on improving healthcare through innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [3]. - The company impacts over 150 million patients annually, highlighting its significant role in the healthcare sector [3].

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a healthcare company recognized for its leadership in pharmaceuticals, medical technologies, and consumer health products. Valued at a market cap of $428 billion, the company focuses on improving human health and well-being through scientific innovation, patient-centered care, and a commitment to addressing some of the world’s most pressing health challenges. The company is expected to announce its fiscal Q3 earnings for 2025 before the market open ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz has been elected Chair of the Board of the Company. Mr. Schwartz succeeds Mr. Amir Boloor, who has decided to step down as a director and Executive Chair of Covalon with effect today. Mr. Schwartz, a member of the Covalon Board since 2008, has previously served as Covalon Board Chair from 2012 unt. ...

Group 1 - Johnson & Johnson (JNJ) is recognized as one of the 13 Best Consistent Dividend Stocks to buy now [1] - The company has a diversified business model, with key growth drivers including cancer treatments like Darzalex and Erleada, and immunology drug Remicade [2] - New product introductions include Imaavy for myasthenia gravis and TAR-200, an investigational treatment for bladder cancer awaiting regulatory feedback [2] Group 2 - Johnson & Johnson is a significant player in the medical device sector, with long-term growth potential in its robotic-assisted surgery system, Ottava, currently in clinical trials [3] - The company is a Dividend King, boasting 63 years of dividend growth, with a current quarterly dividend of $1.30 per share and a dividend yield of 2.92% as of September 12 [3]

Company Overview - Teleflex Incorporated is a global provider of medical technologies focused on improving health and quality of life [2] - The company aims to become the most trusted partner in healthcare, offering a diverse portfolio in various therapy areas including anesthesia, emergency medicine, interventional cardiology, radiology, surgical, vascular access, and urology [2] Product Portfolio - Teleflex is home to several trusted brands such as Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™, and Weck™, all united by a common purpose [3] Upcoming Events - Management of Teleflex will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 3:20 p.m. (ET) [1] - A live audio webcast of the presentation will be available on the investor section of the Teleflex website [1]

Group 1 - Stryker will host an Investor Day on November 13, 2025, at 2:30 p.m. Eastern Time in Mahwah, New Jersey [1] - A live audio webcast of the session will be available on Stryker's official website, with a replay accessible afterward [1] - The recording will be archived in the Investor Relations section of the website [1] Group 2 - Stryker is a global leader in medical technologies, focusing on improving healthcare outcomes [2] - The company offers innovative products and services in MedSurg, Neurotechnology, and Orthopaedics, impacting over 150 million patients annually [2]

Core Insights - Stryker will participate in the 2025 Wells Fargo Securities Healthcare Conference on September 4, 2025 [1] - The session will feature a Fireside Chat with Andy Pierce and Jason Beach at 2:15 pm Eastern Time [1] - A live audio webcast and replay will be available on Stryker's official website [2] Company Overview - Stryker is a global leader in medical technologies, focusing on improving healthcare outcomes [3] - The company offers innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [3] - Stryker impacts over 150 million patients annually through its offerings [3] Contact Information - Investor inquiries can be directed to Jason Beach at 269-385-2600 or jason.beach@stryker.com [4] - Media inquiries can be directed to Kim Montagnino at 269-385-2600 or kim.montagnino@stryker.com [4]